Crossmark

Obinutuzumab en glomerulonefritis focal y segmentaria resistente al tratamiento

Crossref DOI link: https://doi.org/10.1016/j.nefro.2024.12.006

Published Print: 2025-04

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Chiliquinga Morales, Byron https://orcid.org/0000-0002-2596-8072
Sánchez Garrote, Pablo https://orcid.org/0009-0003-5096-9549
Rodríguez Gómez, Astrid https://orcid.org/0000-0003-2565-8784
Martin Varas, Carmen https://orcid.org/0000-0001-6645-963X
García Gutiérrez, Paulo

Saiz González, Ana https://orcid.org/0000-0001-7110-450X
Calle García, Leonardo

Santos Alonso, Carlos https://orcid.org/0000-0002-7644-7736
Muñoz Martínez, Claudia https://orcid.org/0000-0002-6884-1493
Losada de la Rosa, Nieves

Morales, Enrique

Fernández-Reyes Luis, María José https://orcid.org/0000-0003-3811-9755
License Information

Text and Data Mining valid from 2025-04-01

Text and Data Mining valid from 2025-04-01

Version of Record valid from 2024-12-16
More Information

This article is maintained by: Elsevier

Article Title: Obinutuzumab en glomerulonefritis focal y segmentaria resistente al tratamiento

Journal Title: Nefrología

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.nefro.2024.12.006

Content Type: simple-article

Copyright: © 2024 Sociedad Española de Nefrología. Published by Elsevier España, S.L.U.